5-ALA fluorescence–guided surgery in pediatric brain tumors—a systematic review

Michael Schwake(University Hospital Münster), Walter Stummer(University of Münster), Stephanie Schipmann(University of Bergen), Michaela Köchling(University Hospital Münster), Michael Müther, Angela Brentrup(University Hospital Münster)

Acta Neurochirurgica

April 13, 2019

10.1007/s00701-019-03898-1

Cited by 67

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

|The Lancet Oncology|2006|3.4k

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

|Neurosurgery|2008|1k

Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients

|Journal of neurosurgery|2000|880

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

|The Lancet|2019|581

What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

|Neurosurgery|2015|368